Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia.

Tong, Steven Y C; Petersiel, Neta

Tong, Steven Y C; Petersiel, Neta.

Tong SYC; University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (S.Y.T., N.P.).
Petersiel N; University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (S.Y.T., N.P.).

Ann Intern Med ; 174(10): JC111, 2021 10.

Article in English | MEDLINE | ID: covidwho-1450938

ABSTRACT

ABSTRACT

SOURCE CITATION Guimarães PO, Quirk D, Furtado RH, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385406-15. 34133856.

Subject(s)

COVID-19; Respiratory Insufficiency; Humans; Piperidines; Pyrimidines; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / COVID-19 Limits: Humans Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google